Sacks & Associates LLC purchased a new position in Alger Concentrated Equity ETF (NYSEARCA:CNEQ – Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 48,172 shares of the company’s stock, valued at approximately $1,957,000. Alger Concentrated Equity ETF comprises about 1.4% of Sacks & Associates LLC’s holdings, making the stock its 22nd largest holding. Sacks & Associates LLC owned approximately 0.06% of Alger Concentrated Equity ETF as of its most recent SEC filing.
Several other large investors also recently made changes to their positions in the stock. R. W. Roge & Company Inc. increased its holdings in shares of Alger Concentrated Equity ETF by 8.5% during the 2nd quarter. R. W. Roge & Company Inc. now owns 12,268 shares of the company’s stock valued at $506,000 after acquiring an additional 961 shares during the last quarter. IFP Advisors Inc bought a new stake in Alger Concentrated Equity ETF during the second quarter worth approximately $78,000. Ascentis Independent Advisors boosted its position in Alger Concentrated Equity ETF by 24.0% during the first quarter. Ascentis Independent Advisors now owns 18,343 shares of the company’s stock worth $571,000 after purchasing an additional 3,556 shares during the period. Royal Bank of Canada boosted its position in Alger Concentrated Equity ETF by 38.9% during the first quarter. Royal Bank of Canada now owns 15,101 shares of the company’s stock worth $470,000 after purchasing an additional 4,230 shares during the period. Finally, Allworth Financial LP grew its holdings in Alger Concentrated Equity ETF by 269.3% during the second quarter. Allworth Financial LP now owns 6,278 shares of the company’s stock valued at $259,000 after purchasing an additional 4,578 shares during the last quarter.
Alger Concentrated Equity ETF Stock Up 0.5%
NYSEARCA:CNEQ opened at $40.86 on Friday. Alger Concentrated Equity ETF has a 12 month low of $29.47 and a 12 month high of $42.15. The firm has a market cap of $3.24 billion, a price-to-earnings ratio of 35.92 and a beta of 1.72. The company’s 50 day moving average is $40.13 and its 200-day moving average is $38.61.
Alger Concentrated Equity ETF Profile
The Alger Concentrated Equity ETF (CNEQ) is an exchange-traded fund that mostly invests in large cap equity. The fund is actively managed, targeting large-cap companies with high growth potential. The fund maintains a concentrated portfolio of no more than 30 stocks, seeking long-term captial appreciation CNEQ was launched on Apr 4, 2024 and is issued by Alger.
Further Reading
- Five stocks we like better than Alger Concentrated Equity ETF
- MarketBeat Week in Review – 10/05 – 10/09
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
Receive News & Ratings for Alger Concentrated Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alger Concentrated Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
